The company was selected to manufacture and supply MDMA for the program set to take place later this year, pending clinical trial approvalVANCOUVER, British Columbia, June 15, 2023 Optimi Health. | June 15, 2023
VANCOUVER, British Columbia, June 15, 2023 (GLOBE NEWSWIRE) Optimi Health Corp. (CSE:OPTI) (OTCQX:OPTHF) (FRA: 8BN) ("Optimi" or the "Company"), an end-to-end drug researcher and formulator licensed by Health Canada
PurMinds Completes Initial Strategic Equity Investment in globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.